0001520649-12-000004.txt : 20120120 0001520649-12-000004.hdr.sgml : 20120120 20120120162702 ACCESSION NUMBER: 0001520649-12-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120118 FILED AS OF DATE: 20120120 DATE AS OF CHANGE: 20120120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sayiner Necip CENTRAL INDEX KEY: 0001338515 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29823 FILM NUMBER: 12537279 MAIL ADDRESS: STREET 1: 400 W CESAR CHAVEZ CITY: AUSTIN STATE: TX ZIP: 78701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SILICON LABORATORIES INC CENTRAL INDEX KEY: 0001038074 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 742793174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 W CESAR CHAVEZ CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 5124168500 MAIL ADDRESS: STREET 1: 400 W CESAR CHAVEZ CITY: AUSTIN STATE: TX ZIP: 78701 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2012-01-18 0 0001038074 SILICON LABORATORIES INC SLAB 0001338515 Sayiner Necip 400 W CESAR CHAVEZ AUSTIN TX 78701 1 1 0 0 President & CEO Common Stock, $0.0001 par value 2012-01-18 4 M 0 25000 32.27 A 294356 D Common Stock, $0.0001 par value 2012-01-18 4 S 0 29500 44.82 D 264856 D Common Stock, $0.0001 par value 2012-01-18 4 S 0 800 43.5413 D 264056 D Common Stock, $0.0001 par value 2012-01-18 4 S 0 2635 44.171 D 261421 D Non-Qualified Stock Option (right to buy) 32.27 2012-01-18 4 M 0 25000 D 2006-09-14 2015-09-14 Common Stock, $0.0001 par value 25000 240000 D Includes shares purchased by Reporting Person through the Issuer's 2009 Employee Stock Purchase Plan on the Plan's two most recent semi-annual purchase dates. Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Price represents the weighted average selling price. Prices range between $42.78 and $43.77. Price represents the weighted average selling price. Prices range between $43.80 and $44.65. Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable. Not applicable per instruction 4(c)(iii). Necip Sayiner 2012-01-20